Editas Medicine says its in vivo gene-editing therapy for hemoglobinopathies has best-in-class potential, but the company plans to out-license or partner that program. Editas is shifting focusing to in vivo gene-editing therapies. The post Editas Medicine Seeks Partner for Ex Vivo Gene-Editing Program as Focus Turns to In Vivo R&D appeared first on MedCity News.
This data note provides new information about waiting lists for Medicaid Home- and Community-Based Services, including a discussion of why waiting lists are an incomplete measure of unmet need and why they are not necessarily comparable across states or over time.
AI holds a lot of promise in supporting employer-sponsored healthcare, including improving patient navigation and billing, according to a new report from Morgan Health. The post Morgan Health: 5 Ways AI Can Improve Employer-Sponsored Healthcare appeared first on MedCity News.
Whether trying to see more patients, retain more staff, expand the organization’s technology stack or bring more dollars in the door, it’s not uncommon for professionals to want to maximize their resources amidst a market influx. The post Want to Maximize Rev Cycle Efficiencies? Here are 3 Considerations appeared first on MedCity News.
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
I asked if I could purchase the brace myself and bring it to the surgery. The answer was an unequivocal no: the health insurer’s contracted rate required me to purchase the brace from the hospital as part of the procedure. The post A 2,100% Markup: My Battle with a Vastly Overpriced Knee Brace — and…
A groundbreaking initiative leverages AI to improve the process of diabetic retinopathy screening
On Tuesday (11 March 2025) the European Commission presented the draft of its new Critical Medicines Act (CMA). The Science Media Centre España writes that the CMA’s objective is: …to address the serious shortage of medicines and healthcare products, reduce external dependence on critical medicines and ingredients — especially from Asia — and guarantee the…
On March 15, 2025, the President signed a full-year “continuing resolution” (CR) that continues funding the federal government through the rest of the fiscal year. It maintains U.S. global health funding at the prior year (FY 2024) level ($10.8 billion).[i] The Full-Year Continuing Appropriations and Extensions Act, 2025, which was passed by the House on…More
Casi un año después que la administración Biden diera luz verde a Florida para convertirse en el primer estado en importar medicamentos recetados más baratos de Canadá —un objetivo de muchos políticos de todas las tendencias, incluido el presidente electo Donald Trump— el programa aún no ha comenzado. El gobernador de Florida, Ron DeSantis, celebró…